Skip to content

A Comperative Study Between Inj Ropivacaine And Inj Bupivacaine in participants to know the best among the two.

Comparative Study Between Inj Hyperbaric Ropivacaine O.75 Percentage And Inj Hyperbaric Bupivacaine 0.5 Percentage In Spinal Anaesthesia In Infraumbilical Surgeries. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068575
Enrollment
100
Registered
2024-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine: Dose- 3.2ml Route- subarachnoid. Frequency- single dose Total Duration- until first rescue analgesia Intervention2: Bupivacaine: Dose- 3.2ml Route- subarachnoid. Frequenc

Sponsors

MVJ Medical College and Research Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Height 150cms - 180cms. Weight 50 to 80kgs. ASA physical status Grade I and II. Patients undergoing elective surgeries under Spinal Anaesthesia.

Exclusion criteria

Exclusion criteria: Intra op change of plan of anaesthesia. Obstetric surgeries. Any Intra-op Blood transfusion cases will be excluded from the study. Patients with spine deformity. Patients with neurological defects. Patients with previous history of spine surgery. Patients with infection in and around the area of spinal procedure.

Design outcomes

Primary

MeasureTime frame
Onset, time of first rescue analgesia and duration of analgesiaTimepoint: Observed every 10 minutes

Secondary

MeasureTime frame
Hemodynamic parameters & side effectsTimepoint: Every 10 minutes

Countries

India

Contacts

Public ContactMohammed Shoeb

Rajiv Gandhi University of Health Sciences

nirmalbc.prasad@gmail.com9341285491

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026